camylofine has been researched along with Colitis, Ulcerative in 1 studies
camylofine: RN given refers to parent cpd; structure
Colitis, Ulcerative: Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN.
Excerpt | Relevance | Reference |
---|---|---|
"The treatment of ulcerative colitis (inflammatory bowel disease, IBD) has been achieved by using colon specific drug delivery system bearing 5-ASA and Camylofine dihydrochloride." | 1.36 | Development and characterization of colon specific drug delivery system bearing 5-ASA and Camylofine dihydrochloride for the treatment of ulcerative colitis. ( Dubey, R; Jain, SK; Omrey, P; Vyas, SP, 2010) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dubey, R | 2 |
Omrey, P | 1 |
Vyas, SP | 1 |
Jain, SK | 1 |
1 other study available for camylofine and Colitis, Ulcerative
Article | Year |
---|---|
Development and characterization of colon specific drug delivery system bearing 5-ASA and Camylofine dihydrochloride for the treatment of ulcerative colitis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Availability; Chitosan; Colitis, Ulcera | 2010 |